Medtronic (Shanghai) Management Co., Ltd., COVIDIEN Covidien, started in the United States in 1867, renamed from the original Tyco Medical in 2007, the world's major medical equipment and disposable medical products manufacturers, merged with Medtronic in 2015
柯惠医疗（Covidien）作为世界上最早的医疗解决方案提供者之一，它的历史可以追溯到Year 1867成立于United States密苏里州圣路易斯的G. Mallinckrodt & Company。2007 年，泰科医疗更名为柯惠医疗（Covidien），并在United States独立上市。品牌名称中的“Co"和“Vi”来自拉丁语，意思是共同和生命。
Covidien Medical Equipment Manufacturing (Shanghai) Co., Ltd., formerly Tyco Healthcare, ranked 343rd in the world's top 500. On June 30, 2007, Tyco Group was split into three independent listed companies, and the original Tyco Healthcare was officially renamed Covidien.
Surgical products
As a pioneer in automated surgical suture staplers, Covidien Surgical Products has a complete line of open and laparoscopic surgical products. For more than 50 years, Covidien's strong R&D capabilities have been working with experienced doctors and experts to develop and design innovative products with excellent safety and ease of use.
Energy-based products
As the world's leading leader and innovator of electrosurgical equipment, Covidien's Energy Products Division has been committed to providing high-quality, safe and reliable electrosurgical products through professional academic promotion to help doctors reduce surgical bleeding and eschar, shorten the operation time, and improve the postoperative recovery of patients.
Vascular therapy and medical supplies
Covidien is a leader in dialysis vascular, deep vein thrombosis prevention and treatment, and medical essentials. In these areas, the Department of Vascular Therapy provides high-tech products to continuously serve patients and help them achieve better clinical outcomes. At the same time, the Department of Vascular Therapy continues to develop new products to improve vascular treatment outcomes through clinical collaboration.
Respiratory & Critical Care Products
Covidien's Respiratory & Monitoring Products Division is designed to provide total solutions for ICUs and anesthesiology, and its products are used in every aspect of the healthcare sector, whether it is patient transportation, emergency care, critical care, surgical recovery, rehabilitation, long-term care or home care.
Sutures and hernia products
As a global leader in wound closure and soft tissue repair, Carvienne suture and hernia product site surgeons and operating room healthcare professionals provide innovative, high-quality products that advance the technology of wound closure and soft tissue repair to provide the best clinical outcomes for patients. Syneture's™ full range of surgical suture products and hernia repair products such as Parietex™ and Parietene™ provide a complete solution for wound closure and soft tissue repair in clinical practice.
Neurological and peripheral vascular interventional products
Covidien is a global leader in providing advanced products for the treatment of vascular diseases. It offers the most comprehensive product line in the field of neurointerventional products, including: spring coils for embolization, liquid embolic agents, occlusion balloons, and vascular remodeling devices and other surgical support devices. In the field of peripheral vascular interventional products, we provide peripheral aluminectomy systems, PTA balloons, peripheral self-expanding stents, bulb expansion stents, embolic protection devices and various surgical auxiliary instruments. Designed to provide clinicians with a comprehensive portfolio of interventional products.
Adhering to the concept of innovation and development, Covidien will continue to provide safer and more effective products to help interventional doctors around the world!
January 27, 2015,Medtronic Corporation (NYSE: MDT), a global leader in medical technology, services and solutionsAnnounced that it has successfully completed the acquisition of Covidien Medical Corporation (NYSE:COV). Under the terms of the merger agreement, Medtronic Inc. and Covidien plc merged to form Medtronic plc. Medtronic Inc. shares will begin trading on the New York Stock Exchange on January 27, 2015.
